Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: incomep who wrote (1377)	6/16/1999 4:18:00 PM
From: Bill Wexler	Respond to of 10293

I don't think CVSN will make a real move until an FDA decision. The key here will be to short immediately after any decision is announced. If FDA approves, you will have a nice short-term runup to short into...if there's a problem, it will be difficult to get an uptick. This will be a classic "sell on the news" situation because the stock has been pumped on unrealistic market size expectations...much like KERA and BTIM. As soon as real news emerges, the speculative fervor deflates rapidly.